This lecture covers the activation of naive CD8+ T cells into cytotoxic T lymphocytes, the generation of CD8+ memory T cells, and the stimulation of anergic CD8+ T cells in the context of cancer vaccines. It discusses the challenges of solid tumors, the types of cancer vaccines, and the use of dendritic cell therapies, including the 2011 Nobel Prize-winning approach.